{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:22:58Z","timestamp":1791559378905,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ahjo.2026.100883","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:21:05Z","timestamp":1788970865000},"page":"100883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacovigilance signals for congenital heart disease related to drug exposure: A disproportionality analysis based on the FAERS database"],"prefix":"10.1016","volume":"70","author":[{"given":"Chun-Lin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ahjo.2026.100883_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2352-4642(19)30402-X","article-title":"Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"4","year":"2020","journal-title":"Lancet Child. Adolesc. Health"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100883_bb0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S2352-4642(19)30429-8","article-title":"Congenital heart disease: a global public health concern","volume":"4","author":"Rossano","year":"2020","journal-title":"Lancet Child. Adolesc. Health."},{"issue":"7","key":"10.1016\/j.ahjo.2026.100883_bb0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2352-4642(23)00051-2","article-title":"Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China","volume":"7","author":"Zhang","year":"2023","journal-title":"Lancet Child. Adolesc. Health."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100883_bb0020","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.309048","article-title":"Neurodevelopmental Abnormalities and Congenital Heart Disease: Insights Into Altered Brain Maturation","volume":"120","author":"Morton","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100883_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295897","article-title":"Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: A nationwide cohort study","volume":"19","author":"Louchet","year":"2024","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.ahjo.2026.100883_bb0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/AOG.0000000000002579","article-title":"Prescription and other medication use in pregnancy","volume":"131","author":"Haas","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"23","key":"10.1016\/j.ahjo.2026.100883_bb0035","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100883_bb0040","doi-asserted-by":"crossref","first-page":"57.e1","DOI":"10.1016\/j.ajog.2018.08.030","article-title":"Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis","volume":"220","author":"Masarwa","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100883_bb0045","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/HYPERTENSIONAHA.116.08773","article-title":"Maternal antihypertensive medication use and congenital heart defects: updated results from the National Birth Defects Prevention Study","volume":"69","author":"Fisher","year":"2017","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.ahjo.2026.100883_bb0050","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2020.2453","article-title":"Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects","volume":"77","author":"Anderson","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.ahjo.2026.100883_bb0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/bcp.12849","article-title":"The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis","volume":"81","author":"B\u00e9rard","year":"2016","journal-title":"Br. J. Clin. Pharm."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100883_bb0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00404-015-3968-7","article-title":"Management of women with epilepsy: from preconception to post-partum","volume":"293","author":"Lagan\u00e0","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ahjo.2026.100883_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1231320","article-title":"Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS)","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100883_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/ceo.14454","article-title":"Drug-associated glaucoma: a real-world study based on the Food and Drug Administration adverse event reporting system database","volume":"53","author":"Wu","year":"2025","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"10.1016\/j.ahjo.2026.100883_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1338902","article-title":"Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database","volume":"15","author":"Zou","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100883_bb0080","article-title":"Risk assessment of the top 50 drugs associated with drug-induced orthostatic hypotension: a disproportionality analysis of the FAERS and JADER databases","volume":"15","author":"Ren","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100883_bb0085","doi-asserted-by":"crossref","first-page":"32059","DOI":"10.1038\/s41598-025-17182-z","article-title":"A comprehensive study on drug-related Raynaud's phenomenon based on the FDA adverse event reporting system","volume":"15","author":"Zheng","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100883_bb0090","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40264-024-01421-9","article-title":"The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100883_bb0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","article-title":"The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf."},{"issue":"10","key":"10.1016\/j.ahjo.2026.100883_bb0100","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1017\/S1047951117002244","article-title":"Nomenclature for congenital and paediatric cardiac disease: the International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Iteration of the International Classification of Diseases (ICD-11)","volume":"27","author":"Franklin","year":"2017","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.ahjo.2026.100883_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1582908","article-title":"Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study","volume":"16","author":"Di","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100883_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40264-020-01027-x","article-title":"A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants","volume":"44","author":"De Vries","year":"2021","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100883_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.02.015","article-title":"Maternal use of bupropion and risk for congenital heart defects","volume":"203","author":"Alwan","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100883_bb0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pd.5846","article-title":"Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease","volume":"41","author":"Melov","year":"2021","journal-title":"Prenat. Diagn."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100883_bb0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamaneurol.2024.0258","article-title":"Risk of major congenital malformations and exposure to antiseizure medication monotherapy","volume":"81","author":"Battino","year":"2024","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.ahjo.2026.100883_bb0130","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/dc23-0256","article-title":"Metformin versus insulin and risk of major congenital malformations in pregnancies with type 2 diabetes: A Nordic Register-based cohort study","volume":"46","author":"Kjerpeseth","year":"2023","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ahjo.2026.100883_bb0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.7326\/M23-2038","article-title":"Metformin use in the first trimester of pregnancy and risk for nonlive birth and congenital malformations: Emulating a target trial using real-world Data","volume":"177","author":"Chiu","year":"2024","journal-title":"Ann. Intern. Med."},{"issue":"23","key":"10.1016\/j.ahjo.2026.100883_bb0140","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.115.017465","article-title":"Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease: A Nationwide Cohort Study","volume":"133","author":"\u00d8yen","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahjo.2026.100883_bb0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12519-022-00582-w","article-title":"Effect of maternal pregestational diabetes mellitus on congenital heart diseases","volume":"19","author":"Chen","year":"2023","journal-title":"World J. Pediatr."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100883_bb0150","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvaf116","article-title":"Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline","volume":"193","author":"Wyckoff","year":"2025","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"10.1016\/j.ahjo.2026.100883_bb0155","article-title":"Mechanisms of action of metformin with special reference to cardiovascular protection","volume":"35","author":"Zilov","year":"2019","journal-title":"DDiabetes Metab. Res. Rev."},{"key":"10.1016\/j.ahjo.2026.100883_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/cdr\/4642838","article-title":"Metformin attenuates myocardial ischemia-reperfusion injury in rats by modulating JNK pathway and inhibiting PANoptosis mechanisms","volume":"2025","author":"Hou","year":"2025","journal-title":"Cardiovasc. Ther."},{"issue":"8","key":"10.1016\/j.ahjo.2026.100883_bb0165","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/bph.13753","article-title":"Metformin attenuates angiotensin II-induced TGF\u03b21 expression by targeting hepatocyte nuclear factor-4-\u03b1","volume":"175","author":"Chen","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ahjo.2026.100883_bb0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024672","article-title":"Associations of maternal diabetes mellitus and adiponectin gene polymorphisms with congenital heart disease in offspring: a case-control study","volume":"100","author":"Luo","year":"2021","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100883_bb0175","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20f13472","article-title":"Major Congenital Malformation Risk After First Trimester Gestational Exposure to Oral or Intravenous Ondansetron","volume":"81","author":"Andrade","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.ahjo.2026.100883_bb0180","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ije\/dyz255","article-title":"Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defect","volume":"49","author":"Lemon","year":"2020","journal-title":"Int. J. Epidemiol."},{"issue":"23","key":"10.1016\/j.ahjo.2026.100883_bb0185","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/jama.2018.18307","article-title":"Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring","volume":"320","author":"Huybrechts","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ahjo.2026.100883_bb0190","article-title":"Comparison of pregnancy outcomes of patients treated with ondansetron vs alternative antiemetic medications in a multinational, population-based cohort","volume":"4","author":"Dormuth","year":"2021","journal-title":"JAMA Netw."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100883_bb0195","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/bcpt.13541","article-title":"Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC)","volume":"128","author":"Damkier","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100883_bb0200","first-page":"175","article-title":"Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature","volume":"76","author":"Casaretti","year":"2011","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100883_bb0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.mjt.0000162013.66614.16","article-title":"Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk","volume":"13","author":"Barbaro","year":"2006","journal-title":"Am. J. Ther."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100883_bb0210","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/QAD.0000000000002443","article-title":"Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy","volume":"34","author":"Lipshultz","year":"2020","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ahjo.2026.100883_bb0215","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2010.08.620","article-title":"Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (national heart, lung, and blood institute cardiovascular status of HAART therapy in HIV-Exposed infants and children cohort study)","volume":"57","author":"Lipshultz","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100883_bb0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/cid\/civ260","article-title":"In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial","volume":"61","author":"Sibiude","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100883_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001635","article-title":"Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1\/CO11)","volume":"11","author":"Sibiude","year":"2014","journal-title":"PLoS Med."},{"issue":"14","key":"10.1016\/j.ahjo.2026.100883_bb0230","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012241","article-title":"HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database","volume":"8","author":"Alonso","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ahjo.2026.100883_bb0235","article-title":"Higher cardiovascular disease risks in people living with HIV: a systematic review and meta-analysis","volume":"14","author":"Zhu","year":"2024","journal-title":"Glob. Health"},{"issue":"46","key":"10.1016\/j.ahjo.2026.100883_bb0240","first-page":"783","article-title":"The Use of Medication in Pregnancy","volume":"116","author":"Dathe","year":"2019","journal-title":"Dtsch. Arztebl. Int."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:36:37Z","timestamp":1790699797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":48,"alternative-id":["S2666602226001722"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100883","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacovigilance signals for congenital heart disease related to drug exposure: A disproportionality analysis based on the FAERS database","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100883"}}